PECAM1 and neoplasm: CD31 immunostaining for microvessels, and fluorescence imaging of Q-dot 605-D-[c(RGDfK)]2 for integrin receptors also revealed the anti-angiogenic efficacy of 188Re-IDA-D-[c(RGDfK)]2 on the tumor tissue.